Apexigen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.07 million compared to USD 28.92 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.6 a year ago.
1st Jan change | Capi. | |
---|---|---|
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |